Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Di Stefano

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Cytopathology|November 21, 2024
Thin-layer cervical sample evaluation: Conventional light microscopy versus digital whole-slide imagingJessica Viti, Chiara Di Stefano, Serena Giunti, et al.
Acta Cytologica|September 26, 2023
Accuracy and Reproducibility of Cytology Triage in a HPV-Based Primary Screening Setting: A Revision of 384 Pap TestsStefania Cannistrà, Francesca Carozzi, Chiara Di Stefano, et al.
Cellular and Molecular Life Sciences : CMLS|May 25, 2010
Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell modelPaola Luciani, Cristiana Deledda, Susanna Benvenuti, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 5, 2025
From the Daily Peer Review of Abnormal Pap Test Slides to the Monitoring of Individual and Laboratory Performances: 5 Years of Data Collection and New Potential (Key) Performance IndicatorsClaudia Giachini, Giampaolo Pompeo, Donella Puliti, et al.
Oncotarget|August 17, 2018
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cellsChiara Di Stefano, Paola Grazioli, Rosaria Anna Fontanella, et al.
Cancer Biology & Medicine|May 21, 2021
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cellsRosaria A Fontanella, Silvia Sideri, Chiara Di Stefano, et al.
Cell Stem Cell|June 13, 2017
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in GlioblastomaTobias L Haas, Maria Rita Sciuto, Lidia Brunetto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Cytopathology|November 21, 2024
Thin-layer cervical sample evaluation: Conventional light microscopy versus digital whole-slide imagingJessica Viti, Chiara Di Stefano, Serena Giunti, et al.
Acta Cytologica|September 26, 2023
Accuracy and Reproducibility of Cytology Triage in a HPV-Based Primary Screening Setting: A Revision of 384 Pap TestsStefania Cannistrà, Francesca Carozzi, Chiara Di Stefano, et al.
Cellular and Molecular Life Sciences : CMLS|May 25, 2010
Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell modelPaola Luciani, Cristiana Deledda, Susanna Benvenuti, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 5, 2025
From the Daily Peer Review of Abnormal Pap Test Slides to the Monitoring of Individual and Laboratory Performances: 5 Years of Data Collection and New Potential (Key) Performance IndicatorsClaudia Giachini, Giampaolo Pompeo, Donella Puliti, et al.
Oncotarget|August 17, 2018
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cellsChiara Di Stefano, Paola Grazioli, Rosaria Anna Fontanella, et al.
Cancer Biology & Medicine|May 21, 2021
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cellsRosaria A Fontanella, Silvia Sideri, Chiara Di Stefano, et al.
Cell Stem Cell|June 13, 2017
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in GlioblastomaTobias L Haas, Maria Rita Sciuto, Lidia Brunetto, et al.
Pageof 1